Ings R - Search Results

1

A Population Pharmacokinetic and Pharmacodynamic Analysis of RP5063 Phase 2 Study Data in Patients with Schizophrenia or Schizoaffective Disorder.

Cantillon M, Ings R, Prakash A, Bhat L. Cantillon M, et al. Among authors: ings r. Eur J Drug Metab Pharmacokinet. 2018 Oct;43(5):573-585. doi: 10.1007/s13318-018-0472-z. Eur J Drug Metab Pharmacokinet. 2018. PMID: 29619682 Free PMC article. Clinical Trial.

2

Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder.

Cantillon M, Prakash A, Alexander A, Ings R, Sweitzer D, Bhat L. Cantillon M, et al. Among authors: ings r. Schizophr Res. 2017 Nov;189:126-133. doi: 10.1016/j.schres.2017.01.043. Epub 2017 Feb 16. Schizophr Res. 2017. PMID: 28215471 Clinical Trial.

3

Pharmacokinetics of RP5063 Following Single Doses to Normal Healthy Volunteers and Multiple Doses Over 10 Days to Stable Schizophrenic Patients.

Cantillon M, Ings R, Bhat L. Cantillon M, et al. Among authors: ings r. Clin Transl Sci. 2018 Jul;11(4):378-386. doi: 10.1111/cts.12518. Epub 2017 Nov 8. Clin Transl Sci. 2018. PMID: 29119704 Free PMC article. Clinical Trial.

4

Initial Clinical Experience of RP5063 Following Single Doses in Normal Healthy Volunteers and Multiple Doses in Patients with Stable Schizophrenia.

Cantillon M, Ings R, Bhat L. Cantillon M, et al. Among authors: ings r. Clin Transl Sci. 2018 Jul;11(4):387-396. doi: 10.1111/cts.12545. Epub 2018 Apr 10. Clin Transl Sci. 2018. PMID: 29637739 Free PMC article. Clinical Trial.

5

Promoting well-being through creativity: how arts and public health can learn from each other.

Cameron M, Crane N, Ings R, Taylor K. Cameron M, et al. Among authors: ings r. Perspect Public Health. 2013 Jan;133(1):52-9. doi: 10.1177/1757913912466951. Perspect Public Health. 2013. PMID: 23308008

6

Welcome to 'microdosing'.

Ings RM. Ings RM. Bioanalysis. 2010 Mar;2(3):371-2. doi: 10.4155/bio.10.9. Bioanalysis. 2010. PMID: 21083244 Free article. No abstract available.

7

Microdosing: a valuable tool for accelerating drug development and the role of bioanalytical methods in meeting the challenge.

Ings RM. Ings RM. Bioanalysis. 2009 Oct;1(7):1293-305. doi: 10.4155/bio.09.107. Bioanalysis. 2009. PMID: 21083052 Review.

8

Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism.

Zhang JY, Zhan J, Cook CS, Ings RM, Breau AP. Zhang JY, et al. Among authors: ings rm. Drug Metab Dispos. 2003 May;31(5):652-8. doi: 10.1124/dmd.31.5.652. Drug Metab Dispos. 2003. PMID: 12695355

9

Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes.

Reinach B, de Sousa G, Dostert P, Ings R, Gugenheim J, Rahmani R. Reinach B, et al. Among authors: ings r. Chem Biol Interact. 1999 Jun 1;121(1):37-48. doi: 10.1016/s0009-2797(99)00089-7. Chem Biol Interact. 1999. PMID: 10418969

10

The application of modelling in toxicokinetics.

Ings RM. Ings RM. Arch Toxicol Suppl. 1994;16:233-41. doi: 10.1007/978-3-642-78640-2_26. Arch Toxicol Suppl. 1994. PMID: 8192586 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page